Thyroid Hormone Use in the United States, 1997–2016

References

1. 1.↵
   IQVIA Institute for Human Data Science. Medicine use and spending in the U.S. A review of 2017 and outlook to 2022. 2018; https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022. Accessed April 8, 2019.
2. 2.↵
   1. Rodriguez-Gutierrez R,
   2. Maraka S,
   3. Ospina NS,
   4. Montori VM,
   5. Brito JP

   . Levothyroxine overuse: time for an about face? Lancet Diabetes Endocrinol 2017;5:246–248.

   OpenUrl
3. 3.↵
   Agency for Healthcare Research and Quality. MEPS HC-181: 2015 full year consolidated data file. Center for Financing, Access, and Cost Trends; Published August 2017. https://meps.ahrq.gov/data_stats/download_data/pufs/h181/h181doc.shtml.
4. 4.↵
   1. Hill SC,
   2. Zuvekas SH,
   3. Zodet MW

   . Implications of the accuracy of MEPS prescription drug data for health services research. Inquiry 2011;48:242–259.

   OpenUrlPubMed
5. 5.↵
   1. Hwang W,
   2. Weller W,
   3. Ireys H,
   4. Anderson G

   . Out-of-pocket medical spending for care of chronic conditions. Health Aff 2001;20:267–78.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Hollowell JG,
   2. Staehling NW,
   3. Flanders WD,
   4. et al

   . Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489–499.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Taylor PN,
   2. Iqbal A,
   3. Minassian C,
   4. et al

   . Falling threshold for treatment of borderline elevated thyrotropin levels—balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med 2014;174:32–39.

   OpenUrl
8. 8.↵
   1. Villar HC,
   2. Saconato H,
   3. Valente O,
   4. Atallah AN

   . Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev 2007;CD003419.
9. 9.↵
   1. Stott DJ,
   2. Rodondi N,
   3. Kearney PM,
   4. et al

   . Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med 2017;376:2534–44.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Feller M,
    2. Snel M,
    3. Moutzouri E,
    4. et al

    . Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA 2018;320:1349–1359.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Rugge JB,
    2. Bougatsos C,
    3. Chou R

    . Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2015;162:35–45.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Lieberman SD,
    2. Ginsburg PB

    . A billion here, a billion there: selectively disclosing actual generic drug prices would save real money. Health Affairs Blog. Available at: https://www.healthaffairs.org/do/10.1377/hblog20170912.061887/full/.